Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

11 trials with published results (13%)

Research Maturity

53 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.4%

7 terminated out of 83 trials

Success Rate

88.3%

+1.8% vs benchmark

Late-Stage Pipeline

22%

18 trials in Phase 3/4

Results Transparency

21%

11 of 53 completed with results

Key Signals

11 with results88% success

Data Visualizations

Phase Distribution

73Total
Not Applicable (23)
P 1 (17)
P 2 (15)
P 3 (9)
P 4 (9)

Trial Status

Completed53
Recruiting10
Unknown8
Terminated7
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

88.3%

Benchmark: 86.5%

Based on 53 completed trials

Clinical Trials (83)

Showing 20 of 20 trials
NCT07340320Phase 2RecruitingPrimary

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

NCT07495956Phase 1RecruitingPrimary

cfMSC Therapy for Diabetes

NCT07282743Phase 2RecruitingPrimary

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

NCT07385547Phase 1RecruitingPrimary

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

NCT05164263Phase 4RecruitingPrimary

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

NCT07350694Not ApplicableRecruiting

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

NCT07167004Not ApplicableRecruiting

The GRoceries Aimed at Increasing Nutrition Study

NCT06561126Not ApplicableRecruitingPrimary

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

NCT07084350Not ApplicableNot Yet RecruitingPrimary

Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients

NCT07107620CompletedPrimary

Dual Task Performance and Type II Diabetes Mellitus

NCT07047248Not ApplicableNot Yet RecruitingPrimary

Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial

NCT03912363Not ApplicableCompletedPrimary

Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids

NCT06030544Phase 2Active Not Recruiting

Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

NCT06652971Phase 1CompletedPrimary

A Clinical Trial to Evaluate the Food Effect of CKD-379

NCT01514838Phase 3TerminatedPrimary

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

NCT01505426Phase 3CompletedPrimary

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

NCT06645418Not ApplicableCompletedPrimary

Relative Hand Grip Strength and Functional Fitness in Diabetic Patient in Egypt

NCT02761018Not ApplicableCompletedPrimary

Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes

NCT06570057Not ApplicableRecruitingPrimary

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

NCT01165190CompletedPrimary

Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans

Scroll to load more

Research Network

Activity Timeline